CAH
Cardinal Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+41/100
Last price
233.44
▲ 0.32 (0.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
232.30
Prev close
233.12
Day high
235.19
Day low
231.65
Volume
1.15M
Market cap
$54.06B
P/E (TTM)
32.24
52W range
151.87 – 258.30
Day trading desk
Gap from prior close
-0.35%
Prior close 233.12
VWAP
233.26
+0.08% from price
Relative volume
1.10×
Normal
Session range
1.53%
231.63 – 235.19
Position in range
51%
Mid range
ATR (14D)
5.69
2.44% of price
Prior day high
234.18
PDH
Prior day low
228.59
PDL
Bid / ask spread
—
Quote not published
Session volume
2.13M
Avg 1.94M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.26%
+2.3%
1M
-5.56%
-6.7%
3M
-1.56%
-6.1%
6M
+9.71%
-8.5%
YTD
+13.60%
-0.7%
1Y
+51.13%
+34.7%
3Y
+168.88%
+86.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CAH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+230.62K
Net buying
Buy transactions
17
482.89K shares
Sell transactions
7
252.27K shares
Net transactions
+24
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
653.54K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | SCHERER MARY C Officer |
SELL | 2.30K | $546.47K | Direct |
| Aug 19, 26 | HOLLAR JASON M Chief Executive Officer |
SELL | 124.53K | $29.38M | Direct |
| Aug 18, 26 | WEITZMAN DEBORAH Officer |
SELL | 7.35K | $1.73M | Direct |
| Aug 18, 26 | ALT AARON E. Chief Financial Officer |
SELL | 42.00K | $9.93M | Direct |
| Aug 18, 26 | MAYER JESSICA L. Officer |
SELL | 29.44K | $6.95M | Direct |
| Aug 18, 26 | MASON STEPHEN M Officer |
SELL | 35.00K | $8.27M | Direct |
| Aug 18, 26 | GREENE MICHELLE D Chief Technology Officer |
SELL | 11.65K | $2.75M | Direct |
| Aug 14, 26 | HOLLAR JASON M Chief Executive Officer |
STOCK | 30.62K | $0 | Direct |
| Aug 14, 26 | ALT AARON E. Chief Financial Officer |
STOCK | 8.08K | $0 | Direct |
| Aug 14, 26 | GREENE MICHELLE D Chief Technology Officer |
STOCK | 2.55K | $0 | Direct |
| Aug 14, 26 | SCHERER MARY C Officer |
STOCK | 765 | $0 | Direct |
| Aug 14, 26 | WEITZMAN DEBORAH Officer |
STOCK | 7.31K | $0 | Direct |
| Aug 14, 26 | PITTEROFF VALERIE CHRISTINE Officer |
STOCK | 2.98K | $0 | Direct |
| Aug 14, 26 | MAYER JESSICA L. Officer |
STOCK | 6.38K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALT AARON E. |
Chief Financial Officer | 20.50K | Sale |
HALL PATRICIA HEMINGWAY |
Director | 28.64K | Stock Award(Grant) |
HOLLAR JASON M |
Chief Executive Officer | 190.60K | Sale |
JOHRI AKHIL |
Director | 22.87K | Stock Award(Grant) |
KENNY GREGORY B |
Director | 64.19K | Stock Award(Grant) |
KILLEFER NANCY |
Director | 27.62K | Stock Award(Grant) |
MASON STEPHEN M |
Officer | 18.06K | Sale |
MAYER JESSICA L. |
Officer | 33.08K | Sale |
SNOW OLA M |
Officer | 15.57K | Sale |
WEITZMAN DEBORAH |
Officer | 77.90K | Sale |
Fundamentals
Market cap$54.06B
Enterprise value$59.59B
Revenue (TTM)$254.25B
Gross profit$9.77B
EBITDA$4.24B
Net income$1.71B
EPS (TTM)$7.24
Free cash flow$4.75B
Total cash$4.86B
Total debt$10.00B
Book value / share$-12.37
Shares outstanding231.56M
Float232.04M
Short % of float3.33%
Dividend yield0.88%
Beta (5Y)0.50
Valuation & profitability ratios
Trailing P/E32.24
Forward P/E16.61
PEG ratio1.17
Price / sales—
Price / book—
EV / revenue0.23
EV / EBITDA14.04
Gross margin3.84%
Operating margin1.33%
Profit margin0.67%
Return on equity—
Return on assets3.72%
Debt / equity—
Current ratio0.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $254.25B | $222.58B | $226.83B | $204.98B | +14.2% |
| Operating revenue | $254.25B | $222.58B | $226.83B | $204.98B | +14.2% |
| Cost of revenue | $244.47B | $214.41B | $219.41B | $198.10B | +14.0% |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | +19.7% |
| Selling, general & admin | $6.13B | $5.38B | $5.00B | $4.80B | +13.9% |
| Total operating expense | $6.60B | $5.85B | $5.28B | $5.08B | +12.9% |
| Operating income | $3.17B | $2.32B | $2.13B | $1.79B | +36.6% |
| Net interest income | -$348.00M | -$215.00M | -$51.00M | -$84.00M | -61.9% |
| Pre-tax income | $2.17B | $2.10B | $1.20B | $663.00M | +3.5% |
| Tax provision | $469.00M | $532.00M | $348.00M | $332.00M | -11.8% |
| Net income | $1.71B | $1.56B | $852.00M | $330.00M | +9.8% |
| Net income to common | $1.71B | $1.56B | $852.00M | $330.00M | +9.8% |
| Basic EPS | 7.27 | 6.48 | 3.48 | 1.00 | +12.2% |
| Diluted EPS | 7.23 | 6.45 | 3.45 | 1.00 | +12.1% |
| EBIT | $2.52B | $2.32B | $1.25B | $747.00M | +8.9% |
| EBITDA | $3.48B | $3.11B | $1.96B | $1.44B | +12.0% |
| Basic shares | 236.00M | 241.00M | 245.00M | 261.00M | -2.1% |
| Diluted shares | 237.00M | 242.00M | 247.00M | 262.00M | -2.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.86B | $3.87B | $5.13B | $4.08B | +25.3% |
| Cash & short-term investments | $4.86B | $3.87B | $5.13B | $4.08B | +25.3% |
| Accounts receivable | $13.81B | $13.24B | $12.08B | $11.11B | +4.3% |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | +2.8% |
| Total current assets | $38.75B | $36.37B | $34.88B | $33.74B | +6.5% |
| Property, plant & equipment | $3.03B | $2.86B | $2.53B | $2.46B | +6.1% |
| Goodwill & intangibles | $13.63B | $12.18B | $6.45B | $6.08B | +11.9% |
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | +7.9% |
| Total current liabilities | $43.90B | $38.90B | $35.64B | $33.74B | +12.9% |
| Current debt | $1.88B | $550.00M | $434.00M | $792.00M | +242.2% |
| Long-term debt | $7.00B | $7.98B | $4.66B | $3.91B | -12.2% |
| Total debt | $8.89B | $8.53B | $5.09B | $4.70B | +4.2% |
| Total liabilities | $60.02B | $55.76B | $48.33B | $46.31B | +7.7% |
| Retained earnings | $2.01B | $783.00M | -$286.00M | -$642.00M | +156.6% |
| Shareholder equity | -$2.88B | -$2.78B | -$3.21B | -$2.96B | -3.7% |
| Working capital | -$5.15B | -$2.52B | -$756.00M | -$3.00M | -104.1% |
| Net tangible assets | -$16.51B | -$14.96B | -$9.66B | -$9.04B | -10.4% |
| Shares issued | 233.00M | 270.68M | 327.00M | 327.00M | -13.9% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $1.71B | $1.57B | $853.00M | $331.00M | +8.7% |
| Depreciation & amortisation | $956.00M | $790.00M | $710.00M | $692.00M | +21.0% |
| Stock-based compensation | $367.00M | $244.00M | $121.00M | $96.00M | +50.4% |
| Change in working capital | $1.66B | -$523.00M | $1.51B | $457.00M | +417.6% |
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | +115.9% |
| Capital expenditure | -$649.00M | -$547.00M | -$511.00M | -$481.00M | -18.6% |
| Investing cash flow | -$2.58B | -$5.59B | -$1.85B | -$454.00M | +53.8% |
| Share buybacks | -$1.36B | -$765.00M | -$750.00M | -$2.00B | -77.5% |
| Dividends paid | -$491.00M | -$494.00M | -$499.00M | -$525.00M | +0.6% |
| Financing cash flow | -$1.60B | $1.94B | -$847.00M | -$3.05B | -182.6% |
| Free cash flow | $4.53B | $1.85B | $3.25B | $2.36B | +144.6% |
| End cash position | $4.86B | $3.87B | $5.13B | $4.08B | +25.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | +4.5% |
| Operating revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | +4.5% |
| Cost of revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | +4.6% |
| Gross profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | +2.5% |
| Selling, general & admin | $1.63B | $1.54B | $1.50B | $1.46B | $1.48B | +5.4% |
| Total operating expense | $1.75B | $1.66B | $1.63B | $1.56B | $1.62B | +5.4% |
| Operating income | $814.00M | $842.00M | $763.00M | $754.00M | $585.00M | -3.3% |
| Net interest income | -$79.00M | -$101.00M | -$88.00M | -$80.00M | -$74.00M | +21.8% |
| Pre-tax income | $554.00M | $392.00M | $630.00M | $598.00M | $384.00M | +41.3% |
| Tax provision | $154.00M | $12.00M | $159.00M | $144.00M | $141.00M | +1,183.3% |
| Net income | $398.00M | $399.00M | $467.00M | $450.00M | $239.00M | -0.3% |
| Net income to common | $398.00M | $399.00M | $467.00M | $450.00M | $239.00M | -0.3% |
| Basic EPS | 1.70 | 1.69 | 1.98 | 1.89 | 1.01 | +0.6% |
| Diluted EPS | 1.70 | 1.69 | 1.97 | 1.88 | 1.00 | +0.6% |
| EBIT | $633.00M | $493.00M | $718.00M | $678.00M | $458.00M | +28.4% |
| EBITDA | $874.00M | $741.00M | $952.00M | $911.00M | $667.00M | +17.9% |
| Basic shares | 234.00M | 235.00M | 236.00M | 238.00M | 239.00M | -0.4% |
| Diluted shares | 235.00M | 236.00M | 237.00M | 239.00M | 240.00M | -0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | +23.3% |
| Cash & short-term investments | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | +23.3% |
| Accounts receivable | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | +1.2% |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | -3.9% |
| Total current assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | +1.8% |
| Property, plant & equipment | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | +3.5% |
| Goodwill & intangibles | $13.63B | $13.70B | $13.98B | $12.11B | $12.18B | -0.5% |
| Total assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | +1.1% |
| Total current liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | +4.6% |
| Current debt | $1.88B | $671.00M | $680.00M | $52.00M | $550.00M | +180.5% |
| Long-term debt | $7.00B | $8.24B | $8.35B | $8.98B | $7.98B | -15.1% |
| Total debt | $8.89B | $8.92B | $9.03B | $9.03B | $8.53B | -0.3% |
| Total liabilities | $60.02B | $59.36B | $60.78B | $57.96B | $55.76B | +1.1% |
| Retained earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783.00M | +16.0% |
| Shareholder equity | -$2.88B | -$2.83B | -$2.88B | -$2.88B | -$2.78B | -1.8% |
| Working capital | -$5.15B | -$3.92B | -$4.08B | -$1.73B | -$2.52B | -31.2% |
| Net tangible assets | -$16.51B | -$16.53B | -$16.86B | -$14.99B | -$14.96B | +0.1% |
| Shares issued | 233.00M | 271.32M | 270.60M | 271.00M | 270.68M | -14.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $400.00M | $380.00M | $471.00M | $454.00M | $243.00M | +5.3% |
| Depreciation & amortisation | $241.00M | $248.00M | $234.00M | $233.00M | $209.00M | -2.8% |
| Stock-based compensation | $58.00M | $129.00M | $87.00M | $93.00M | $153.00M | -55.0% |
| Change in working capital | $748.00M | $846.00M | -$106.00M | $173.00M | $633.00M | -11.6% |
| Operating cash flow | $1.69B | $1.82B | $686.00M | $973.00M | $1.53B | -7.2% |
| Capital expenditure | -$264.00M | -$146.00M | -$131.00M | -$108.00M | -$232.00M | -80.8% |
| Investing cash flow | -$281.00M | -$181.00M | -$1.98B | -$142.00M | -$1.63B | -55.2% |
| Share buybacks | -$350.00M | -$250.00M | -$383.00M | -$375.00M | $0 | -40.0% |
| Dividends paid | -$120.00M | -$120.00M | -$122.00M | -$129.00M | -$120.00M | 0.0% |
| Financing cash flow | -$490.00M | -$483.00M | -$519.00M | -$110.00M | $656.00M | -1.4% |
| Free cash flow | $1.43B | $1.68B | $555.00M | $865.00M | $1.29B | -14.8% |
| End cash position | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | +23.3% |
Options analytics
Put / call volume
0.07
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
190.00
-18.6% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
379
Contracts, this expiry
Put volume
25
Contracts, this expiry
Heaviest call OI
190.00
0 contracts
Heaviest put OI
200.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.42 | 2.60 | +7.4% |
| Mar 2026 | 2.79 | 3.17 | +13.7% |
| Dec 2025 | 2.37 | 2.63 | +11.2% |
| Sep 2025 | 2.17 | 2.55 | +17.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.94 | 14 | $66.53B | +3.9% |
| Next quarter | 3.12 | 14 | $68.32B | +4.1% |
| Current year | 12.56 | 17 | $265.77B | +4.5% |
| Next year | 14.06 | 17 | $281.95B | +6.1% |
Analyst targets & ownership
Mean target$270.33
High target$292.00
Low target$235.00
Implied upside15.80%
Analyst count15
ConsensusBUY
Strong buy / Buy3 / 11
Hold3
Sell / Strong sell0 / 0
Held by insiders0.28%
Held by institutions91.49%
Institutions holding1.98K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
225.58
+3.49% from price
SMA 20
228.30
+2.25% from price
SMA 50
232.85
+0.25% from price
SMA 100
225.98
+3.30% from price
SMA 200
218.38
+6.89% from price
EMA 12
228.28
+2.26% from price
EMA 26
229.60
+1.67% from price
EMA 50
229.93
+1.53% from price
RSI (14)
55.7
Neutral
MACD (12,26,9)
-1.31
Hist 1.06
ATR (14)
5.69
2.44% of price
Realised vol 30D
23.0%
Annualised
Bollinger upper
240.05
20, 2σ
Bollinger lower
216.54
20, 2σ
50 / 200 cross
Golden
232.85 vs 218.38
Trend bias
Above 200
+6.89%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
23.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-20.6%
Peak to trough
Max drawdown 5Y
-21.0%
Peak to trough
ATR 14
5.69
2.44% of price
Beta (reported)
0.50
5Y monthly, from filing
Short interest
Shares short
6.67M
Prior 6.39M
Change vs prior
+4.3%
Shorts adding
% of float
3.33%
Normal
% of shares out
2.88%
Against total outstanding
Days to cover
4.5
Liquid
Float
232.04M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 26 | RBC Capital | INITIATED | — | Outperform |
| Aug 13, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 13, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 13, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 12, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 12, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Aug 12, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Aug 12, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 12, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Jul 24, 26 | Citigroup | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$2.06 / yr
Forward yield0.88%
5-year avg yield1.70%
Payout ratio28.33%
Ex-dividend dateOct 1, 2026
Next pay dateOct 15, 2026
Last split3:2
Split dateApr 23, 2001
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-01
Proxy Statements
DEF 14A · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-08-05
Annual report of employee stock purchase
11-K · 2026-06-23
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-03-23
Headlines
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Zacks · 16h ago
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · 16h ago
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
Zacks · 17h ago
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
StockStory · 17h ago
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Zacks · 1d ago
Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
GlobeNewswire · 2d ago
How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story
Simply Wall St. · 2d ago
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Motley Fool · 3d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.